SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001415889-13-000732
Filing Date
2013-04-12
Accepted
2013-04-12 13:20:49
Documents
6
Period of Report
2013-04-01
Effectiveness Date
2013-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ectepredef14aapr12013.htm DEF 14A 689396
2 burkesig1.jpg GRAPHIC 4965
3 ectelogo.jpg GRAPHIC 7015
4 graph1.jpg GRAPHIC 44456
5 proxycard1n.jpg GRAPHIC 171468
6 proxycard2n.jpg GRAPHIC 114941
  Complete submission text file 0001415889-13-000732.txt   1163759
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35218 | Film No.: 13758278
SIC: 3845 Electromedical & Electrotherapeutic Apparatus